Longliv Ventures
Overview
Longliv Ventures, established in 2018, is the corporate venture capital arm of CK Hutchison. The firm focuses on early-stage investments in the digital healthcare sector, aiming to discover and support innovative consumer digital health solutions that enhance the management of health and wellness. Longliv Ventures leverages the resources of the CK Hutchison Group to provide funding, strategic value, and sales channels to digital health companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AceAge Inc. | Dec 2020 | Series A | Lead |
| ApoWiser | Jun 2022 | Seed | Lead |
| Sight Diagnostics | Aug 2020 | Series D | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Longliv Ventures based?
Longliv Ventures is headquartered in Herzliya, Tel Aviv District, Israel.
When was Longliv Ventures founded?
Longliv Ventures was founded in 2018.
How many portfolio companies does Longliv Ventures have?
Longliv Ventures has 4 portfolio companies in Caplight's dataset.
What are some companies in Longliv Ventures's portfolio?
Portfolio companies visible on Caplight include AceAge Inc., ApoWiser, Sight Diagnostics.
What was Longliv Ventures's most recent investment shown here?
Longliv Ventures's most recent investment in this portfolio sample was in ApoWiser in 2022.
What sectors does Longliv Ventures focus on?
Longliv Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Frontier & Industrial Tech.
What company stages does Longliv Ventures focus on?
Stage focus information for Longliv Ventures is not publicly available.
What is Longliv Ventures's AUM?
Longliv Ventures's assets under management are estimated between $0.0 and $50.0M.